German research study indicates Covid vaccine that creates T-cells ‘gives better immune response than current jabs

Covid vaccine that creates T-cells ‘gives better immune response than current jabs’ A new vaccine designed to specifically create T-cells against Covid produces a better immune response than the alternatives already in use, according to trial data. YahooNews

A new vaccine designed to specifically create T-cells against Covid produces a better immune response than the alternatives already in use, according to trial data.

The CoVac-1 jab has been developed and made by academics at the University of Tubingen, in Germany.

The cells form part of the immune response to protect people against infections and often work in tandem with antibodies. However, while antibody levels often decline over time and need boosting, T-cells have the ability to stay in the bloodstream for several years.

Evidence is emerging that T-cell levels from vaccines may be key in conferring long-term protection against Covid, but studying the level of them in a person's system is difficult.

"The induction of SARS-CoV-2 T-cell immunity is a central goal for vaccine development and of particular importance for patients with congenital or acquired B-cell deficiencies," the researchers wrote in a paper published in Nature. "The latter comprise cancer patients with disease or treatment-related immunoglobulin deficiency." ...